Provided by Tiger Fintech (Singapore) Pte. Ltd.

MiMedx Group, Inc.

6.30
-0.0250-0.40%
Volume:240.39K
Turnover:1.51M
Market Cap:929.78M
PE:23.19
High:6.39
Open:6.33
Low:6.22
Close:6.32
Loading ...

Craig-Hallum Sticks to Their Buy Rating for MiMedx Group (MDXG)

TIPRANKS
·
10 Dec 2024

MIMEDX to Participate in Upcoming Investor Conferences

GlobeNewswire
·
04 Dec 2024

Institutional investors own a significant stake of 43% in MiMedx Group, Inc. (NASDAQ:MDXG)

Simply Wall St.
·
02 Dec 2024

Northland Securities Sticks to Its Buy Rating for MiMedx Group (MDXG)

TIPRANKS
·
27 Nov 2024

Poseida Therapeutics, Inc. (PSTX) Hit a 52 Week High, Can the Run Continue?

Zacks
·
27 Nov 2024

We Ran A Stock Scan For Earnings Growth And MiMedx Group (NASDAQ:MDXG) Passed With Ease

Simply Wall St.
·
22 Nov 2024

How Much Upside is Left in MiMedx (MDXG)? Wall Street Analysts Think 37.12%

Zacks
·
20 Nov 2024

Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY) and MiMedx Group (MDXG)

TIPRANKS
·
17 Nov 2024

MiMedx Group Inc : Craig-Hallum Raises Target Price to $14 From $12

THOMSON REUTERS
·
15 Nov 2024

Craig-Hallum Reaffirms Their Buy Rating on MiMedx Group (MDXG)

TIPRANKS
·
15 Nov 2024

Northland Securities Sticks to Their Buy Rating for MiMedx Group (MDXG)

TIPRANKS
·
15 Nov 2024

MiMedx provided update on LCDs regarding skin substitute

TIPRANKS
·
14 Nov 2024

MIMEDX’s Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDs

GlobeNewswire
·
14 Nov 2024

MiMedx Group's (NASDAQ:MDXG) Promising Earnings May Rest On Soft Foundations

Simply Wall St.
·
07 Nov 2024

ChromaDex Corporation (CDXC) Hit a 52 Week High, Can the Run Continue?

Zacks
·
05 Nov 2024

Can MiMedx (MDXG) Climb 77.92% to Reach the Level Wall Street Analysts Expect?

Zacks
·
04 Nov 2024

MIMEDX to Participate in Upcoming Investor Conferences

GlobeNewswire
·
04 Nov 2024